A total of 57 scientific and professional organizations have formed the Spanish Research Network on Persistent COVID (REiCOP).With the aim of continuously increasing the knowledge about the disease and regularizing the health status of the people affected by this new disease.
really, recopThe format of a scientific association will bring together all scientific and professional organizations, along with affected groups, who are interested in improving the health care provided to patients with Persistent Covid, who have been infected with the coronavirus in about 10 years. represent percentages.
«It is the beginning of what has to be developed with tenacity, work and effort. The formation of this network is the beginning of something great”, remarked the President of the Spanish Society of General Practitioners (SEMG) during the presentation ceremony, Antonio Fernandez Pro Ledesma.
In this sense, he explained that “as a patient I could not be too pleased to have achieved this milestone in medicine, that it has been placed patient in the center, in a shared support in which he or she is involved in the process of healing and recovery from illness», commented Esther Rodriguez, representative of the patient group and the network’s second vice president.
Similarly, the representative of the Spanish Society of Infectious Diseases and Clinical Microbiology and the first vice president of REiCOP, Jose Ramon BlancoWho has remembered the importance of knowing the needs of patients to restore their health before they become infected with the virus.
main strategic lines
Various strategic lines have already been defined, such as, for example, updating Clinical guide to persistent covid patient careWhich is expected to be published in early 2023, as well as a mobile application to help professionals diagnose and make decisions.
In addition, REICOP will also propose a training program on COVID-19 continuously aimed at health professionals and with the aim of supporting the University for the same. Academic Curriculum 2022-2023. In this sense, the second vice president of the organization has highlighted the need to train doctors in post-viral situations.
One of the projects proposed by REiCOP is the development of clinical registry primary careComplemented by hospital care services to identify clinical and genetic factors associated with the development of persistent COVID.
On the other hand, it has started patient recruitmentFor genetic studies and subsequent analysis of the collected samples. Notably, more than a hundred samples are expected to be analyzed next month.
Other projects also include the development and validation of care scales based on information obtained in clinical registry, to assess comprehensive and holistic approach For patients suffering from persistent COVID-19, beyond monitoring their every symptom. The research teams will meet next month to begin the first steps in designing a wider scale.
The research will also focus on projects aimed at studying the effectiveness of the network various drugsThe implications for specific treatment, or analysis of health care, flow through the patient’s experience.
